Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omacor for Secondary Prevention of Cardiovascular Events in Hemodialysis Patients
NCT00257283Phase 4Completed
- Sponsor
- Pronova BioPharma
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3-acid ethyl esters in cardiovascular disease (CVD), sponsored by Pronova BioPharma. Started Nov 2002; status: completed.
02
Drugs
omega-3-acid ethyl esters
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT00257283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00257283.